{
    "eid": "2-s2.0-85041125005",
    "title": "Prognostic factors affecting outcomes in patients with malignant GI bleeding treated with a novel endoscopically delivered hemostatic powder",
    "cover-date": "2018-04-01",
    "subject-areas": [
        {
            "@_fa": "true",
            "$": "Radiology, Nuclear Medicine and Imaging",
            "@code": "2741",
            "@abbrev": "MEDI"
        },
        {
            "@_fa": "true",
            "$": "Gastroenterology",
            "@code": "2715",
            "@abbrev": "MEDI"
        }
    ],
    "keywords": [],
    "authors": [
        "Rapat Pittayanon",
        "Rungsun Rerknimitr",
        "Alan Barkun"
    ],
    "citedby-count": 25,
    "ref-count": 26,
    "ref-list": [
        "The burden of gastrointestinal and liver disease around the world",
        "Diagnosis and management of nonvariceal upper gastrointestinal hemorrhage: European Society of Gastrointestinal Endoscopy (ESGE) guideline",
        "Management of bleeding GI tumors",
        "Management of patients with ulcer bleeding",
        "The role of endoscopy in the patient with lower GI bleeding",
        "Natural history of acute upper GI bleeding due to tumours: short-term success and long-term recurrence with or without endoscopic therapy",
        "The efficacy of Hemospray in patients with upper gastrointestinal bleeding from tumor",
        "Endoscopic hemostatic devices",
        "Aggressive endoscopy in critically ill patients with upper gastrointestinal bleeding and cancer",
        "Outcome of endoscopic therapy for cancer bleeding in patients with unresectable gastric cancer",
        "Prognosis following upper gastrointestinal bleeding",
        "Early clinical experience of the safety and effectiveness of Hemospray in achieving hemostasis in patients with acute peptic ulcer bleeding",
        "A novel hemostatic powder for upper gastrointestinal bleeding: a multicenter study (the \u201cGRAPHE\u201d registry)",
        "Use of the endoscopically applied hemostatic powder TC-325 in cancer-related upper GI hemorrhage: preliminary experience (with video)",
        "Methodology for randomized trials of patients with nonvariceal upper gastrointestinal bleeding: recommendations from an international consensus conference",
        "Multivariable prognostic models: issues in developing models, evaluating assumptions and adequacy, and measuring and reducing errors",
        "Hemospray for treatment of acute bleeding due to upper gastrointestinal tumours",
        "The successful endoscopic hemostasis factors in bleeding from advanced gastric cancer",
        "Pharmacological manipulation of gastric juice: thrombelastographic assessment and implications for treatment of gastrointestinal haemorrhage",
        "Topical hemostatic agents: a systematic review with particular emphasis on endoscopic application in GI bleeding",
        "Acute haemorrhage from gastric malignancy",
        "Severe upper gastrointestinal tumor bleeding: endoscopic findings, treatment, and outcome",
        "Endoscopic treatment of major bleeding from advanced gastroduodenal malignant lesions",
        "Randomized comparison between chemotherapy plus best supportive care with best supportive care in advanced gastric cancer",
        "Clinical benefit of palliative radiation therapy in advanced gastric cancer",
        "Hemostatic powder TC-325 in the management of upper and lower gastrointestinal bleeding: a two-year experience at a single institution"
    ],
    "affiliation": [
        {
            "affiliation-city": "Bangkok",
            "@id": "60022183",
            "affilname": "King Chulalongkorn Memorial Hospital",
            "@href": "https://api.elsevier.com/content/affiliation/affiliation_id/60022183",
            "affiliation-country": "Thailand"
        },
        {
            "affiliation-city": "Montreal",
            "@id": "60006558",
            "affilname": "Centre Universitaire de Sant\u00e9 McGill",
            "@href": "https://api.elsevier.com/content/affiliation/affiliation_id/60006558",
            "affiliation-country": "Canada"
        }
    ],
    "funding": []
}